# Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin Tone

> **NCT07162623** · NA · ACTIVE_NOT_RECRUITING · sponsor: **NovoBliss Research Pvt Ltd** · enrollment: 60 (estimated)

## Conditions studied

- Hyperpigmentation

## Interventions

- **OTHER:** Oziva Bioactive Gluta Fizzy Effervescent Tablets 4.1 g containing Glutathione
- **OTHER:** Placebo Effervescent Tablets 4.1 g

## Key facts

- **NCT ID:** NCT07162623
- **Lead sponsor:** NovoBliss Research Pvt Ltd
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-09-02
- **Primary completion:** 2026-04-15
- **Final completion:** 2026-04-15
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-01-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162623, "Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Oziva Bioactive Gluta Fizzy Effervescent Tablets on Subjects With Facial Dark Spots Such as Pimple Marks, Sunspots, Age Spots and Uneven Skin Tone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07162623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*